Lineage Cell Therapeutics
LCTX
LCTX
108 hedge funds and large institutions have $56.4M invested in Lineage Cell Therapeutics in 2019 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 9 closing their positions.
Holders
108
Holders Change
+12
Holders Change %
+12.5%
% of All Funds
2.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
21
Increased
27
Reduced
19
Closed
9
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$10K
